An EconoTimes perspective

Emma Forton Magavern

Clinical Research Fellow, Centre of Clinical Pharmacology and Precision Medicine, William Harvey Research Institute, Queen Mary University of London

Clinical Research Fellow, Centre of Clinical Pharmacology and Precision Medicine, William Harvey Research Institute, Queen Mary University of London Emma is a Medical doctor and a PhD candidate at the William Harvey Research Institute, QMUL, working with Professor Mark Caulfield. She completed a BA in English prior to her MD and subsequent MScs in Bioethics and Genomics. Through training in clinical medicine, humanities, genetics and pharmacology she has developed an interest in the scientific merits, clinical potential and implementation challenges of pharmacogenomics. She was co-secretary of the RCP/BPS working group on pharmacogenomics and led the ESC pharmacotherapy working group pharmacogenomics position paper.